Edwards Lifesciences Selected Fundamentals

EW -- USA Stock  

USD 150.28  0.47  0.31%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

Number of Shares Shorted Analysis

Number of Shares Shorted is total amount of shares that are currently sold short by investors. When stock is sold short, the short seller assumes the responsibility of buying the stock back at a lower price. The speculator will make money if the stock goes down in price or will experience loss if the stock price goes up.
Edwards Lifesciences 
Shares Shorted 
Shorted by Public 
by Institutions 
3.98 M

About Number of Shares Shorted

If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect price of the stock.
Compare to competition
Based on recorded statements Edwards Lifesciences Corporation has 3.98 M of outstending shares currently sold short by investors. This is 9.24% higher than that of the Healthcare sector, and significantly higher than that of Healthcare Products industry, The Number of Shares Shorted for all stocks is 22.85% lower than the firm.

Edwards Lifesciences Fundamental Drivers Relationships

Edwards Lifesciences Corporation is rated # 2 in price to book category among related companies. It is rated # 2 in price to sales category among related companies fabricating about  0.94  of Price to Sales per Price to Book. The ratio of Price to Book to Price to Sales for Edwards Lifesciences Corporation is roughly  1.06 

Peer Comparison

Edwards Lifesciences Shares Outstanding Comparison
  Shares Outstanding 
      Edwards Lifesciences Comparables 
Edwards Lifesciences is rated below average in shares outstanding category among related companies.

Current Edwards Lifesciences financial ratios